Nishan Sengupta, PhD

Articles by Nishan Sengupta, PhD

Thromboembolism Prophylaxis in Medical Inpatients: Effect on Outcomes and Costs

ByOnur Baser, PhD, MS,Nishan Sengupta, PhD,Anne Dysinger, MA,Li Wang, MA, PhD

June 15th 2012

VTE prophylaxis is underutilized in medical patients in US hospitals, but the occurrence of VTE has a major clinical and economic impact.

Analysis of Venous Thromboprophylaxis Duration and Outcomes in Orthopedic Patients

ByPhilip S. Wells, MD,Bijan J. Borah, PhD,Nishan Sengupta, PhD,Dylan Supina, PhD,Heather P. McDonald, MSc,Louis M. Kwong, MD

November 19th 2010

Extended-duration thromboprophylaxis (>14 days) for total hip replacement/total knee replacement was associated with significantly lower risk for thromboembolic and bleeding events than short-duration thromboprophylaxis.

Latest Updated Articles

Analysis of Venous Thromboprophylaxis Duration and Outcomes in Orthopedic Patients
November 19th 2010
Thromboembolism Prophylaxis in Medical Inpatients: Effect on Outcomes and Costs
June 15th 2012

Nishan Sengupta, PhD

Articles by Nishan Sengupta, PhD

Thromboembolism Prophylaxis in Medical Inpatients: Effect on Outcomes and Costs

Analysis of Venous Thromboprophylaxis Duration and Outcomes in Orthopedic Patients

Latest Updated Articles

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Student Mental Health, Success Tied to Future Health and Affordability

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Mobile Integrated Health Valuable in Heart Failure, but Payment Lags

US Employer Health Care Costs Projected to Rise 9.5% in 2027